Resource Type: Clinical Webinars

Webinar Description:

Dr. Rosalyn Plotzker, MD, MPH, will discuss available at-home testing options for sexually transmitted infections (STIs) and cervical cancer, treatment updates for Mycoplasma genitalium and gonorrhea, and STI prevention updates for both sexually transmitted Shigella and doxycycline post-exposure prophylaxis (doxy-PEP).

Learning Objectives:

1. Utilize at least one alternative oral therapy for gonorrhea
2. Provide counseling on available at-home testing for STIs and cervical cancer
3. Discuss methods for preventing sexually transmitted Shigella

Presenter:

• Rosalyn Plotzker, MD, MPH
  • Assistant Professor | UCSF Department of Epidemiology and Biostatistics
  • Clinical Faculty | California Prevention Training Center
  • Provider | UCSF Anal Neoplasia, Clinic, Research and Education (ANCRE) Center
  • Public Health Medical Officer | CDPH STD Control Branch

Webinar Resources:

• Slides
• Transcript
• Question and Answer

Webinar Description:

This webinar will explore strategies for providing informed, compassionate, and patient-centered counseling to individuals considering sterilization. Presenters will discuss how to support autonomy and informed decision-making within the context of clinical, ethical, and policy considerations. Participants will gain insight into current evidence, communication approaches, and referral pathways that promote equitable access to sterilization and related reproductive health services.

Learning Objectives:

1. Balance patient-centered care with federal consent requirements.
2. Recognize historical and ongoing injustices in reproductive health.
3. Apply reproductive justice principles to patient-centered contraceptive counseling and care.
4. Compare the safety and effectiveness of surgical contraception, vasectomy, and long-acting reversible contraception methods.
5. Identify best practices for referrals and explore options for procedural training.

Presenters:

• Eleanor Bimla Schwarz, MD, MS (She/Her)
  • Professor of Medicine at the University of California, San Francisco, and Chief of the Division of General Internal Medicine at San Francisco General Hospital
  • Previously served as a Senior Medical Expert for the U.S. Department of Veterans Affairs, and on the U.S. Food and Drug Administration’s Advisory Committee on Reproductive Health Drugs
  • Medical Consultant for the California Department of Health Care Services, Office of Family Planning from 2014-2016

• Lindsey M. Wilder-Piper, MSN, WHNP-BC, SAFE-A, CNM-s (She/They)
  • Sexual and reproductive health nurse practitioner
  • Trains providers and sees patients in Massachusetts at Health Quarters, in New Hampshire at the Joan G. Lovering Health Center, and in Maine at the local federally qualified health centers

• Finn Wilder-Piper, MSN, FNP-BC (They/Them)
  • An out, loud, and visibly queer nonbinary nurse practitioner
  • Provides comprehensive sexual and reproductive health care, gender-affirming care, and abortion care in Midcoast Maine, as well as via telehealth
  • Approaches care and education from a background in reproductive and social justice, with the goal of increasing access to competent, equitable, compassionate care for all

Webinar Resources:

• Slides
• Transcript

Sterilization Resources:

• All About Tubal Sterilization (English)
• All About Tubal Sterilization (Spanish)
• All About Vasectomy (English)
• All About Vasectomy (Spanish)

Vasectomy Sample Forms:

• Vasectomy Pre-Procedure Instructions
• Vasectomy Consent Form
• Vasectomy Protocol
• EMR for Vasectomy
• Post Vasectomy Patient Education Form
• Post Vasectomy On Call

October 30, 2025

Description:

This webinar will explore best practices for working with adolescents and young adults, considering issues of minor consent and confidentiality, sexual and reproductive health, and youth autonomy in navigating the health care system. We will focus on how to best prepare youth to begin the lifelong journey of managing their health care needs. 

Learning Objectives:

• Differentiate between consent and confidentiality for minors in clinical settings.
• Apply the concepts of consent and confidentiality to sexual and reproductive health.
• Identify the fundamentals of care for adolescents and young adults.

Speaker:

Sarah Nathan, PhD, MS, FNP
Nurse Practitioner, University of California, San Francisco (UCSF) School of Medicine, Adolescent and Young Adult Medicine Clinic
Associate Clinical Professor, Department of Family Health Care Nursing, UCSF School of Nursing
Practicing clinically since 2008, focusing on primary and sexual and reproductive health care for adolescents and young adults
PhD in Nursing, specializing in health policy

Resources:

• Slides
• Transcript

August 26, 2025

Description:

This webinar is tailored for family planning providers, offering critical insights and practical knowledge to enhance your practice and support your patients through perimenopause and menopause. As a family planning provider, you are vital in supporting patients through these significant life stages. This session will equip you with the latest information on the pathophysiology, symptomatology, contraception options, and patient-centered management strategies for perimenopause and menopause.

Learning Objectives:

• Define and understand the pathophysiology of perimenopause and menopause.
• Describe the most common symptoms of perimenopause and menopause.
• Explain the contraception options in perimenopause.
• Support a patient-centered approach to the management of perimenopausal and menopausal symptoms.

Speakers:

Jennifer Karlin, MD, PhD
Associate Professor, Department of Family & Community Medicine, University of California, San Francisco School of Medicine
Project Principal Investigator, National Clinician Consultation Center, Medical Consultant for the CA Family PACT Program, California Prevention Training Center
Associate Editor, Annals of Family Medicine

Resources:

• Slides
• Transcript
• Q&A
• NAMS 2022 Hormone Therapy Position Statement of The North American Menopause Society
• NAMS 2023 Nonhormone Therapy Position Statement of The North American Menopause Society

June 24, 2025

Description:

The 2024 CDC MEC and SPR included a number of significant changes that clinicians should be aware of. In addition to new recommendations regarding people with chronic kidney disease, the 2024 MEC includes revised risk categories for some people using depot-medroxyprogesterone acetate (DMPA). The SPR has an expanded section of pain management for IUD placement and bleeding problems with implant use. The QFP Guidelines are an update of the 2014 QFP and contain state-of-the-art contraceptive counseling guidelines. The changes will be discussed in detail, as well as a review of the MEC/SPR app and job aids available from the CDC.

Learning Objectives:

• List the contraceptives that are considered to be Category 3 or 4 in people with chronic kidney disease.
• For people using DMPA, list three medical conditions that had changes in their U.S. MEC safety category.
• Describe two changes in the section of the SPR on bleeding irregularities during implant use.

Speakers:

Jennifer Karlin, MD, PhD
Associate Professor, Department of Family & Community Medicine, University of California, San Francisco School of Medicine
Project Principal Investigator, National Clinician Consultation Center, Medical Consultant for the CA Family PACT Program, California Prevention Training Center
Associate Editor, Annals of Family Medicine

Michael Policar, MD, MPH
Professor Emeritus, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco School of Medicine
Clinical Fellow, National Family Planning and Reproductive Health Association (NFPRHA)

Resources:

• Slides
• Transcript
• Q&A

May 5, 2025

Description:

Transgender and gender diverse (TGD) people represent a growing subset of patient populations, yet many continue to report a lack of provider knowledge when it comes to TGD health. This session will build on TGD health terminology and competency essentials presented in Part 1, Chosen Family: Contraception for Transgender and Gender Diverse People, by reviewing evidence-based recommendations for contraception, fertility, and family-building counseling.

Learning Objectives:

• Describe three new pieces of data that providers can incorporate into their counseling for patients initiating testosterone gender-affirming hormone therapy.
• Identify two aspects of contraceptive counseling that providers can incorporate into the care of patients initiating estrogen gender-affirming hormone therapy.
• Explain existing data on fertility and gender-affirming hormone therapy and how this data can inform their decision-making for patients and families.

Speakers:

Chance Krempasky FNP-BC, WHNP-BC, AAHIVS
Director of Medicine and Director of Education at the Community Healthcare Network in New York City.
Providing care for the LGBTQIA+ communities for the past 15 years.
Lead author of “Chapter 22: Contraception for Lesbian, Gay, Bisexual, Transgender, Gender Diverse, Queer/Questioning, Intersex, and Asexual Individuals” in the 22nd Edition of Contraceptive Technology.

Miles Harris FNP-BC, AAHIVS
Trans and nonbinary-identified family nurse practitioner and the Director of Gender-Affirming Care for UC Davis Health.
Assistant Clinical Professor at the UC Davis Betty Irene Moore School of Nursing.
Published in The American Journal of Obstetrics and Gynecology and The Nurse Practitioner, as well as textbooks including Pharmacotherapeutics for Advanced Practice Nurse Prescribers and the 22nd Edition of Contraceptive Technology.

Resources:

• Slides
• Transcript

March 19, 2025

Description:

This webinar explains why contraception is a vital component of health care for clients
and their families. Learn how to proactively address contraception stigma and
misinformation and how to advocate for contraceptive access among your colleagues,
clients, and community.

Learning Objectives:

• Reproductive life planning in the United States
• Person-centered counseling
• Benefits versus risks of contraception
• Responding to patient concerns

Speaker:

Carrie Cwiak, MD, MPH, FACOG
Chief of the Obstetrics and Gynecology Inpatient Service Line for Emory Healthcare and Vice Chair of Quality for the Department of Gynecology and Obstetrics.
Director of the Complex Family Planning Fellowship.
Active in training, speaking, and writing to educate trainees and providers; advocating for the people of Georgia; and collaborating in research.

Resources:

• Slides
• Transcript
• Handout

October 29, 2024

Description:

Transgender and gender diverse (TGD) people represent a growing subset of patient
populations, yet many continue to report a lack of provider knowledge when it comes to
TGD health. This session will build on TGD health terminology and competency
essentials by reviewing evidence-based recommendations for contraceptive counseling.

Learning Objectives:

• List 5 terms related to gender-inclusive sexual and reproductive health.
• Describe barriers faced by TGD people seeking contraception.
• Give examples of contraceptive considerations for TGD people.
• Discuss available contraceptives for TGD people.

Speakers:

Chance Krempasky FNP-BC, WHNP-BC, AAHIVS
Associate Director of Medicine- Education at Callen Lorde Community Health Center in New York City.
Professor of Clinical Nursing at Columbia University School of Nursing, in the Certificate in Professional Achievement in TGNB Health Care Program.
Lead author of “Chapter 22: Contraception for Lesbian, Gay, Bisexual, Transgender, Gender Diverse, Queer/Questioning, Intersex, and Asexual Individuals” in the 22nd Edition of Contraceptive Technology.

Miles Harris FNP-BC, AAHIVS
Trans and nonbinary-identified family nurse practitioner and the Director of Gender-Affirming Care for UC Davis Health.
Assistant Clinical Professor at the UC Davis Betty Irene Moore School of Nursing.
Published in The American Journal of Obstetrics and Gynecology and The Nurse Practitioner, as well as textbooks including Pharmacotherapeutics for Advanced Practice Nurse Prescribers and 22nd Edition of Contraceptive Technology.

Resources:

• Slides
• Transcript
• Handout

September 17, 2024

Description:

Many patients report that their intrauterine device (IUD) placement was uneventful and relatively comfortable. Others describe the experience as the worst pain of their life. We can’t predict which patients will experience severe anxiety, pain, or trauma from IUD placement or removal. However, what we can do is universally address the potential for pain and anxiety with counseling and diverse management strategies. Data now confirms the effectiveness of cervical blocks and a variety of pharmacologic and non-pharmacologic management strategies to mitigate against potential pain and anxiety with IUD placement and removal.

Learning Objectives:

• List 3 non-pharmacologic interventions designed to prevent pain with IUD placement.
• Demonstrate anticipatory guidance for vasovagal prevention.
• Describe the evidence for providing a cervical block to reduce pain with IUD placement.

Speakers:

Joely Pritzker, MS, FNP-C
Nurse Practitioner at Vista Community Clinic
National Trainer for Envision SRH & the PATH Framework Sexual and Reproductive Health Trainer and Consultant
Contributing author for the 22nd Edition of Contraceptive Technology

Patty Cason, RN, MS, FNP-BC
Assistant Clinical Professor
UCLA School of Nursing
President, Envision SRH

Resources:

• Slides
• Transcript